| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,132,317 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$6,132,317 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-24 |
4 |
OE |
$27.07 |
$812,100 |
D/D |
30,000 |
262,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-03 |
4 |
AS |
$82.00 |
$820,000 |
D/D |
(10,000) |
18,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-06 |
4 |
S |
$84.31 |
$843,080 |
D/D |
(10,000) |
18,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-07 |
4 |
OE |
$26.49 |
$855,839 |
D/D |
32,308 |
234,434 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-11-06 |
4 |
AS |
$29.68 |
$909,073 |
D/D |
(29,882) |
17,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-03-26 |
4 |
AS |
$46.74 |
$934,800 |
D/D |
(20,000) |
41,428 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-06-25 |
4 |
OE |
$19.47 |
$973,500 |
D/D |
50,000 |
294,562 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-05 |
4 |
AS |
$35.57 |
$1,004,008 |
D/D |
(28,225) |
232,550 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-09-15 |
4 |
OE |
$16.53 |
$1,007,100 |
D/D |
60,000 |
87,634 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-07 |
4 |
AS |
$31.99 |
$1,042,660 |
D/D |
(32,308) |
232,550 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-24 |
4 |
AS |
$35.57 |
$1,067,100 |
D/D |
(30,000) |
232,550 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-05-18 |
4 |
AS |
$25.00 |
$1,108,027 |
D/D |
(44,314) |
24,201 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-13 |
4 |
OE |
$26.49 |
$1,146,885 |
D/D |
43,295 |
272,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-10-28 |
4 |
OE |
$22.93 |
$1,168,559 |
D/D |
50,962 |
121,699 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2014-02-18 |
4 |
S |
$34.55 |
$1,181,221 |
D/D |
(34,192) |
17,551 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-09 |
4 |
OE |
$19.47 |
$1,200,302 |
D/D |
50,000 |
250,242 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-03 |
4 |
OE |
$23.98 |
$1,245,210 |
D/D |
50,000 |
236,720 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
AS |
$31.47 |
$1,258,800 |
D/D |
(40,000) |
265,922 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-12 |
4 |
OE |
$26.49 |
$1,324,500 |
D/D |
50,000 |
245,845 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2014-04-02 |
4 |
OE |
$13.28 |
$1,338,600 |
D/D |
90,000 |
69,227 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2008-09-03 |
4 |
S |
$67.07 |
$1,341,482 |
D/D |
(20,000) |
6,500 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-04 |
4 |
OE |
$27.07 |
$1,353,500 |
D/D |
50,000 |
244,325 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-23 |
4 |
OE |
$27.07 |
$1,353,500 |
D/D |
50,000 |
272,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
OE |
$18.00 |
$1,440,000 |
D/D |
80,000 |
252,130 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-13 |
4 |
AS |
$33.69 |
$1,460,768 |
D/D |
(43,295) |
232,550 |
0 |
% |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
